Shattuck Labs, Inc. (STTK) stock
STTKNasdaqPharmaceutical PreparationsFiscal year ends December 31
$4.81−0.24 (-4.75%)
Close on Nov 12, 2026Market cap $482.75MP/E –Yield –
Shattuck Labs cash
Cash and short-term investments held at the end of each period.
Shattuck Labs's cash was $196.30M at Sep 30, 2026. For fiscal 2025 it was $78.10M, up 7.0% from the year before. The highest annual figure on record is $335.40M in fiscal 2020.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $78.10M | +7.0% |
| FY2024 | Dec 31, 2024 | $73.00M | -44.1% |
| FY2023 | Dec 31, 2023 | $130.60M | -19.0% |
| FY2022 | Dec 31, 2022 | $161.30M | -40.0% |
| FY2021 | Dec 31, 2021 | $268.80M | -19.9% |
| FY2020 | Dec 31, 2020 | $335.40M | +758.1% |
| FY2019 | Dec 31, 2019 | $39.09M | +23.5% |
| FY2018 | Dec 31, 2018 | $31.64M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $196.30M | +128.0% |
| Q2 FY2026 | Jun 30, 2026 | $208.30M | +312.5% |
| Q1 FY2026 | Mar 31, 2026 | $90.40M | +48.4% |
| Q4 FY2025 | Dec 31, 2025 | $78.10M | +7.0% |
| Q3 FY2025 | Sep 30, 2025 | $86.10M | -4.4% |
| Q2 FY2025 | Jun 30, 2025 | $50.50M | -52.0% |
| Q1 FY2025 | Mar 31, 2025 | $60.90M | -46.9% |
| Q4 FY2024 | Dec 31, 2024 | $73.00M | -44.1% |
| Q3 FY2024 | Sep 30, 2024 | $90.10M | -10.9% |
| Q2 FY2024 | Jun 30, 2024 | $105.30M | -10.2% |
| Q1 FY2024 | Mar 31, 2024 | $114.60M | -15.4% |
| Q4 FY2023 | Dec 31, 2023 | $130.60M | -19.0% |
| Q3 FY2023 | Sep 30, 2023 | $101.10M | -45.4% |
| Q2 FY2023 | Jun 30, 2023 | $117.20M | -45.3% |
| Q1 FY2023 | Mar 31, 2023 | $135.50M | -43.4% |
| Q4 FY2022 | Dec 31, 2022 | $161.30M | -40.0% |
| Q3 FY2022 | Sep 30, 2022 | $185.10M | -36.2% |
| Q2 FY2022 | Jun 30, 2022 | $214.20M | -29.7% |
| Q1 FY2022 | Mar 31, 2022 | $239.20M | -25.5% |
| Q4 FY2021 | Dec 31, 2021 | $268.80M | -19.9% |
| Q3 FY2021 | Sep 30, 2021 | $290.20M | +115.1% |
| Q2 FY2021 | Jun 30, 2021 | $304.80M | +132.6% |
| Q1 FY2021 | Mar 31, 2021 | $321.20M | +752.2% |
| Q4 FY2020 | Dec 31, 2020 | $335.40M | +758.1% |
| Q3 FY2020 | Sep 30, 2020 | $134.90M | +785.9% |
| Q2 FY2020 | Jun 30, 2020 | $131.04M | +314.1% |
| Q1 FY2020 | Mar 31, 2020 | $37.69M | – |
| Q4 FY2019 | Dec 31, 2019 | $39.09M | – |
| Q3 FY2019 | Sep 30, 2019 | $15.23M | – |
| Q4 FY2018 | Dec 31, 2018 | $31.64M | – |
See a number that looks wrong?